FDA Investigator Evelyne L Weaver
Evelyne L Weaver has conducted inspections on 2 sites in 1 countries as of 04 Mar 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
04 Mar 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Evelyne L Weaver:
Alan E Mehl,
Barbara I Rogolsky,
Brittany D Terhar,
Carl J Montgomery,
Chilton L Ng,
Chris A Sack,
Danial S Hutchison,
Daniel R Hurt,
Dr. Sriram Subramaniam, PhD,
Farhana Khan,
Gretchen Lf Trendel,
Gwyn G Dickinson,
Ingrid Y Johnson,
James D Planchon,
Jill J Tillman,
Julie N Vosilus,
Kellia N Hicks,
Linda R Kuchenthal,
Lisa L Gilliam,
Marion D Wimberly, Jr,
Martin K Yau, PhD,
Matthew R Sleeter,
Michael S Smoker,
Michele L Obert,
Michele Perry Williams,
Monique M Brooks,
Neal L Adams,
Rita K Kabaso,
Shirley J Berryman,
Shwnji Susie Lee,
Susanna E Ford,
Susie H Lee,
Suzanna E Ford,
Tara L Breckenridge,
Tara L Greene,
Tara L King,
Victoria A Wagoner,
Vinh T Phan,
Warren J Lopicka,
Wayne D Mcgrath,
Zachary A Bogorad
Evelyne L Weaver's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2003 | FDA 483 | Sanofi - Aventis US LLC - Form 483, 2003-04-09 |
April, 2003 | FDA 483 Response | Sanofi - Aventis US LLC - Form 483R, 2003-04-29 |
July, 2002 | FDA 483 Response | Catalent CTS, LLC - Form 483R, 2002-07-10 |
July, 2002 | FDA 483 | Catalent CTS, LLC - Form 483, 2002-07-03 |
April, 2003 | EIR | Sanofi - Aventis US LLC - EIR, 2003-04-09 |
July, 2002 | EIR | Catalent CTS, LLC - EIR, 2002-07-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more